WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

PROSPECTIVE STUDY ON DRUG USE PATTERN IN HIGH LEVEL CHOLESTEROL PATIENTS AT A TERTIARY CARE HOSPITAL

Farshad Rezakhaninejad* and Balakeshav Ramaiah

ABSTRACT

Objectives: To evaluate the effects of systemic drug medications used in treating high blood cholesterols at a tertiary care hospital. Methods: A hospital-based prospective study was conducted for 6 months inwards at Bangalore Baptist Hospital (BBH). The medical history of inpatients was reviewed carefully before prescribing the anti-cholesterol drugs. The prescription patterns are well-designed and data collection was done through a survey form which included lab parameters like HDL, and LDL along with patient demographic, and previous medications. Results: out of the total patients studied (n=134), most of them were on statins (93.28 %). Among them, Atorvastatin was prescribed more with 52.98% followed by rosuvastatin (23.13%). Conclusions: According to this metadata collected males are more exposed to LLDs and they are suffering from coronary heart diseases. Among the most prescribed LLDs are statins and fibrates, whereas atorvastatin is the most commonly prescribed drug in treating LLDs. There is a need to elevate the quality of LLTs prescribed to patients to address their safe keeping in view that rationally using lipid-lowering agents along with significant doses of statins could significantly lower the morbidity and mortality in patients.

Keywords: LLDs, lipid-lowering agents, Statins, Atorvastatin, Rosuvastatin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More